Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
TI Mughal, A Yong, RM Szydlo, F Dazzi… - British Journal of …, 2001 - elibrary.ru
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
TI Mughal, A Yong, RM Szydlo… - British journal of …, 2001 - pubmed.ncbi.nlm.nih.gov
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
TI Mughal, A Yong, RM Szydlo… - British Journal of …, 2001 - research.sahmri.org.au
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse.
TI Mughal, A Yong, RM Szydlo… - British Journal of …, 2001 - search.ebscohost.com
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse.
TI Mughal, A Yong, RM Szydlo, F Dazzi… - British Journal of …, 2001 - europepmc.org
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
TI Mughal, A Yong, RM Szydlo… - British Journal of …, 2001 - research.birmingham.ac.uk
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
TI Mughal, A Yong, RM Szydlo, F Dazzi… - British Journal of …, 2001 - kclpure.kcl.ac.uk
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
[引用][C] Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
TI MUGHAL, A YONG, J APPERLEY… - British journal of …, 2001 - pascal-francis.inist.fr
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after
allogeneic stem cell transplant define the risk of subsequent relapse CNRS Inist Pascal-Francis …
allogeneic stem cell transplant define the risk of subsequent relapse CNRS Inist Pascal-Francis …
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
TI Mughal, A Yong, RM Szydlo, F Dazzi… - British Journal of …, 2001 - eprints.soton.ac.uk
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …
chronic myeloid leukaemia (CML), were in molecular remission (MR). The 103 patients were …